A Phase 1b, Multicenter, Randomized, Placebo-controlled, Observer-blinded, Dose-escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield ®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar.
Condition: Schistosomiasis Intervention: Biological: Sm-p80 + GLA-SE Sponsor: International Vaccine Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection of Sexually Transmitted Infections and Bacterial Vaginosis
Condition: STI Intervention: Device: GIFT Device Sponsors: University of Cape Town; Macfarlane Burnet Institute for Medical Research and Public Health Ltd; Desmond Tutu HIV Foundation; London School of Hygiene and Tropical Medicine; UMC Utrecht; Institut Pasteur; Institut Pasteur de Madagascar; Hitotsubashi Univers ity Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2023 Category: Research Source Type: clinical trials
